JP2003500010A5 - - Google Patents

Download PDF

Info

Publication number
JP2003500010A5
JP2003500010A5 JP2000604066A JP2000604066A JP2003500010A5 JP 2003500010 A5 JP2003500010 A5 JP 2003500010A5 JP 2000604066 A JP2000604066 A JP 2000604066A JP 2000604066 A JP2000604066 A JP 2000604066A JP 2003500010 A5 JP2003500010 A5 JP 2003500010A5
Authority
JP
Japan
Prior art keywords
amino acids
mature
seq
polypeptide
segment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000604066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003500010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/006182 external-priority patent/WO2000053631A1/en
Publication of JP2003500010A publication Critical patent/JP2003500010A/ja
Publication of JP2003500010A5 publication Critical patent/JP2003500010A5/ja
Pending legal-status Critical Current

Links

JP2000604066A 1999-03-11 2000-03-09 哺乳動物サイトカイン;関連試薬および方法 Pending JP2003500010A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26790199A 1999-03-11 1999-03-11
US09/267,901 1999-03-11
PCT/US2000/006182 WO2000053631A1 (en) 1999-03-11 2000-03-09 Mammalian cytokines; related reagents and methods

Publications (2)

Publication Number Publication Date
JP2003500010A JP2003500010A (ja) 2003-01-07
JP2003500010A5 true JP2003500010A5 (cg-RX-API-DMAC7.html) 2007-05-10

Family

ID=23020618

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000604066A Pending JP2003500010A (ja) 1999-03-11 2000-03-09 哺乳動物サイトカイン;関連試薬および方法

Country Status (9)

Country Link
EP (2) EP1942114A3 (cg-RX-API-DMAC7.html)
JP (1) JP2003500010A (cg-RX-API-DMAC7.html)
AR (1) AR022890A1 (cg-RX-API-DMAC7.html)
AT (1) ATE420894T1 (cg-RX-API-DMAC7.html)
AU (1) AU3873200A (cg-RX-API-DMAC7.html)
CA (1) CA2366706A1 (cg-RX-API-DMAC7.html)
DE (1) DE60041393D1 (cg-RX-API-DMAC7.html)
ES (1) ES2319958T3 (cg-RX-API-DMAC7.html)
WO (1) WO2000053631A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha
US7045283B2 (en) * 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
EP1623011B1 (en) 2003-05-09 2013-01-02 Janssen Biotech, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
CA2613818C (en) 2005-06-30 2013-08-27 Centocor, Inc. Anti-il-23 antibodies, compositions, methods and uses
ME02705B (me) 2005-08-31 2017-10-20 Merck Sharp & Dohme Inženjerisana anti-il-23 antitela
SI3219328T1 (sl) 2005-12-29 2020-10-30 Janssen Biotech, Inc. Človeška protitelesa proti-IL-23, sestavki, postopki in uporabe
CN103396489A (zh) 2007-02-23 2013-11-20 默沙东公司 工程改造的抗IL-23p19抗体
HUE042172T2 (hu) 2007-02-23 2019-06-28 Merck Sharp & Dohme Genetikailag elõállított anti-il-23P19 antitestek
MX2009009167A (es) 2007-02-28 2009-09-04 Schering Corp Terapia de combinacion para el tratamiento de trastornos inmunes.
CA2679381A1 (en) 2007-02-28 2008-09-04 Schering Corporation Engineered anti-il-23r antibodies
US9803010B2 (en) 2012-06-27 2017-10-31 Merck Sharp & Dohme Corp. Crystalline anti-human IL-23p19 antibodies
UA117466C2 (uk) 2012-12-13 2018-08-10 Мерк Шарп Енд Доме Корп. СТАБІЛЬНИЙ СКЛАД У ВИГЛЯДІ РОЗЧИНУ АНТИТІЛА ДО IL-23p19
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
CN110913906A (zh) 2017-05-02 2020-03-24 默沙东公司 抗lag3抗体的制剂和抗lag3抗体与抗pd-1抗体的共制剂
MX2021004356A (es) 2018-10-18 2021-05-31 Merck Sharp & Dohme Llc Formulaciones de anticuerpos anti-rsv y metodos de uso de las mismas.
MA54089A (fr) 2018-10-31 2022-02-09 Merck Sharp & Dohme Anticorps anti-pd-1 humain et procédés d'utilisation associés
JP7503056B6 (ja) 2018-11-07 2024-07-16 メルク・シャープ・アンド・ドーム・エルエルシー 抗lag3抗体および抗pd-1抗体の共-製剤
MA55149A (fr) 2018-11-20 2021-09-29 Janssen Biotech Inc Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23
EP3972690A4 (en) 2019-05-23 2023-07-05 Janssen Biotech, Inc. METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE USING COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF-ALPHA
CA3183927A1 (en) 2020-05-21 2021-11-25 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0088994B1 (en) 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5470952A (en) * 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists
ES2305024T3 (es) * 1995-08-01 2008-11-01 F. Hoffmann-La Roche Ag Receptores para interleuquina-12 humana.
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
WO1998031811A1 (en) * 1997-01-16 1998-07-23 Genetics Institute, Inc. Member of the hematopoietin receptor superfamily
ATE273391T1 (de) * 1997-02-03 2004-08-15 Amgen Inc Neurotrophischer faktor nnt-1
US5741772A (en) * 1997-02-03 1998-04-21 Amgen Inc. Neurotrophic factor NNT-1
WO1998049307A1 (en) * 1997-05-01 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like receptor
EP1001982A1 (en) * 1997-06-30 2000-05-24 Human Genome Sciences, Inc. Cardiotrophin-like cytokine
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
NZ522634A (en) * 1997-12-03 2004-02-27 Genentech Inc PRO243 encoding a polypeptide with homology to chordin and antibodies and vectors
WO1999035264A1 (en) * 1998-01-09 1999-07-15 Immunex Corporation H14 dna and polypeptides
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
EP1181366B2 (en) * 1999-06-01 2013-08-21 Merck Sharp & Dohme Corp. Mammalian receptor proteins; related reagents and methods
FR2804435A1 (fr) * 2000-01-27 2001-08-03 Pf Medicament COMPLEXE ISOLE COMPRENANT UNE PROTEINE NNT-1 ET EN OUTRE AU MOINS UNE PROTEINE CLF-1 ET/OU UNE PROTEINE sCNTFRalpha

Similar Documents

Publication Publication Date Title
Yamasaki et al. Identification of four nuclear transport signal-binding proteins that interact with diverse transport signals
JP2004509617A5 (cg-RX-API-DMAC7.html)
JP2003534013A5 (cg-RX-API-DMAC7.html)
WO2018233575A1 (zh) 阻断型cd47纳米抗体及其用途
JPH02500329A (ja) ターゲット化多機能蛋白質
JPH07502640A (ja) シグナルペプチド、選択的相互作用ポリペプチド及び膜固定配列をコードする組換えdna配列
JP2002508933A (ja) 二官能分子
CN113698475B (zh) 抗猪δ冠状病毒N蛋白的单克隆抗体和猪δ冠状病毒胶体金快速检测试纸条
WO2021197358A1 (zh) 一种抗pd-l1和pd-l2抗体及其衍生物和用途
CA2240409A1 (en) Mammalian cx3c chemokine genes
WO2004067564B1 (en) Compositions against cancer antigen liv-1 and uses thereof
CN109293739B (zh) 一种a3超家族通用肿瘤抗原多肽及其应用
WO1993024630A1 (en) Reagent for agglutination assays
CN106928358B (zh) 一种CD105纳米抗体Nb168
CN116284424B (zh) 抗鼠抗体可结晶段的纳米抗体及其应用
CN106928360B (zh) 一种CD105纳米抗体Nb68
CN106928355B (zh) 一种CD105纳米抗体Nb184
CN106928359B (zh) 一种CD105纳米抗体Nb59
CN110958886A (zh) 恶性疟原虫和间日疟原虫疫苗
CN116813765A (zh) Rab8蛋白的特异性抗体及其制备方法与应用
CN120518757B (zh) 一种聚乙二醇化多价抗西尼罗病毒单链抗体
CN119978135B (zh) Sumo标签蛋白的特异性抗体及其制备方法与应用
CN116640209B (zh) Rab11蛋白的特异性抗体及其制备方法与应用
CN102276700A (zh) 一种猪戊型肝炎病毒抗原表位及它的应用
JP2002510712A5 (cg-RX-API-DMAC7.html)